Minimally Invasive Surgery Market

Report Code MD 1250
Published in Mar, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Minimally Invasive Surgery Market Size by Product (Robotics, Imaging, Instrument (Handheld, inflation, Guiding, electrosurgery, endoscopy)), Application (CVD, thoracic, neuro, ENT, OB/GYN, orthopedic), End-user, and Surgery volume - Global Forecast to 2029

Overview

The size of global minimally invasive surgery market in terms of revenue was estimated to be worth $79.3 billion in 2024 and is poised to reach $173.9 billion by 2029, growing at a CAGR of 17.0% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. An increase in chronic disorders and the aging population, increasing research & funding initiatives from organizations, and worldwide advancement in surgical procedures are a few drivers that collectively contribute to the growth of the minimally invasive surgery market, and as healthcare technologies continue to evolve, the demand for minimally invasive surgical procedure is expected to rise further in the upcoming years. However, challenges for high cost, regulatory issues can limits the market growth.

Attractive Opportunities in the Minimally Invasive Surgery Market

ASIA PACIFIC

The rising prevalence of chronic disorder worldwide, growing funding investments from public & private organizations for research on minimally invasive surgery are expected to drive the market growth in APAC.

Increasing incidence of chronic disorder and research on MIS by key companies have resulted in the development are the major factors driving market growth.

Ongoing research and advancements in MIS technology for chronic disorder is expected to offer growth opportunities for market players

North America holds the largest share of 41.0% of the minimally invasive surgery market in 2023.

The market growth in the Asia Pacific region is attributed to the rise in surgical procedures and improving healthcare infrastructure in the region.

Global Minimally Invasive Surgery Market Dynamics

DRIVER: Increase adoption of MIS over open surgeries

Laparoscopic procedures are less invasive and save costs in terms of pre- and post-operation care and the length of stay in hospitals. These surgeries result in less blood loss, fewer postoperative complications, and a shorter recovery time for patients. In addition, minimally invasive surgeries are increasingly being covered by health insurance providers in select countries. Physicians prefer minimally invasive surgeries over traditional open surgeries as they consider it to be a cost-saving opportunity for hospitals.

RESTRAINT: High cost of Robotic systems

Robot-assisted surgeries are much more expensive than minimally invasive surgeries. This often results in deferred or altogether avoided treatments. The high cost of robotic surgery is further increased by the fact that the annual maintenance cost of robots is around USD 125,000. Hospital budget cuts were similar throughout European countries, and more cuts are anticipated in the upcoming years. Budget cuts have made cost-containment measures necessary in many areas of hospital operations.

 

OPPORTUNITY: Emerging markets- growth opportunities

Emerging markets are evolving into growth areas for the minimally invasive surgery. A myriad of factors contribute to the growth opportunities within these markets, attributed to their low regulatory barriers, improvements in healthcare infrastructure, growing patient population, and rising healthcare expenditure, escalating disposable incomes, and a burgeoning aging demographic. Asia Pacific region are more adaptive and business-friendly than those in developed countries. This, along with the increasing competition in mature markets, has drawn top players in the minimally invasive surgery market to focus on emerging countries.

CHALLENGE: High degree of market consolidaton

The minimally invasive surgery market is highly consolidated. Only key companies are able to afford high capital invaestments as well as the high cost of research & development and manufacturing. It will prevent new entrant to enter the minimally invasive surgery market. Top player salso enjoys the high degree of brand loyalty. Whereas new entrant have to compete with existing key players to offer and set themselves by developing innovative product offerings.

Global Minimally Invasive Surgery Market Ecosystem Analysis

Major companies in this market include well-established and financially stable suppliers of minimally invasive surgery. Prominent companies in this market include Medtronic plc (Ireland), Johnson & Johnson (US), Stryker corporation (US), NuVasive (US), Abbott Laboratories (US), Zimmer Biomet holdings (Warsaw), Boston Scientific Corporation (US), GE Healthcare (US) among several others.

 

Surgical devices segment to register largest market share of minimally invasive surgery industry in the year 2023.

Based on the product, the minimally invasive surgery market is segmented into Surgical Devices, Imaging & Visualization Systems, Endoscopy Devices, Electrosurgical Devices, and Medical Robotics. Surgical Devices segment to register largest market share in the forecast period of 2023-2029. The surgical devices further divided into Handheld instruments, laparoscopy devices, guiding devices and inflation system. Key drivers fostering the expansion of minimally invasive surgery (MIS) via surgical devices encompass ongoing technological advancements, which continuously elevate the precision, adaptability, and safety of these instruments. Furthermore, the market's growth is further bolstered by the introduction of advance surgical technologies by key industry players.

Nerological Surgery segment is the highest market rate application segment of minimally invasive surgery industry in the forecasted year 2024-2029.

The Neurological surgery application segment register highest market rate in the forecasted year 2024-2029 . Key factors propelling the adoption of minimally invasive surgery (MIS) in neurological procedures include advancements in technology, particularly in imaging modalities and surgical instrumentation, which enable more precise and minimally invasive interventions. Additionally, the imperative to minimize patient morbidity, lower post-operative complications, and accelerate recovery periods serves as a significant impetus for the adoption of MIS in neurological surgery. Furthermore, evolving healthcare paradigms prioritizing value-based care and patient-centric outcomes further propel the integration of MIS in neurological surgery.

Asia Pacific Region Holds the Largest Share of the Minimally Invasive Surgery Market

The minimally invasive surgery market is divided into key regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2023, North America held the largest market share in the global minimally invasive surgery market. However, the Asia Pacific region is anticipated to exhibit the highest CAGR during the forecast period. This growth is primarily attributed to the a rise in healthcare budgets, demographic shift with a rapidly aging population,and investing in healthcare infrastructure. Patients increasingly seek minimally invasive alternatives to traditional surgery due to the perceived benefits, such as shorter hospital stays, reduced pain, and quicker recovery. As patient awareness and demand for MIS options rise, healthcare providers are more likely to offer and promote these procedures. This includes advancements in surgical techniques and the adoption of advanced minimally invasive surgery. Additionally, the market in the Asia Pacific region is set to receive a boost from the growing number of local manufacturers offering minimally invasive surgery products.

 
 

Recent Developments of Minimally Invasive Surgery Market industry

  • In 2023, Medtronic receives CE Mark approval for Affera Mapping and Ablation System to treat atrial arrhythmias. In 2023, J&J MONARCH Platform is the first minimally invasive, robotic-assisted technology approved for bronchoscopy in China with significant burden of lung cancer.
  • In 2023, Stryker’s Q Guidance System for cranial applications received US FDA clearance to support cranial surgeries.

Key Market Players

KEY PLAYERS IN THE Minimally Invasive Surgery Market INCLUDE

Want to explore hidden markets that can drive new revenue in Minimally Invasive Surgery Market?

Scope of the Report

Report Attribute Details
Market Revenue in 2024 $79.3 billion
Projected Revenue by 2029 $173.9 billion
Revenue Rate Poised to Grow at a CAGR of 17.0%
Market Driver Increase adoption of MIS over open surgeries
Market Opportunity Emerging markets- growth opportunities

 

Key Questions Addressed by the Report

What is the projected market revenue value of the global minimally invasive surgery market?
The global minimally invasive surgery market boasts a total revenue value of $173.9 billion by 2029.
What is the estimated growth rate (CAGR) of the global minimally invasive surgery Market?
The global minimally invasive surgery market has an estimated compound annual growth rate (CAGR) of 17.0% and a revenue size in the region of $79.3 billion in 2024.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Minimally Invasive Surgery Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
29
RESEARCH METHODOLOGY
34
EXECUTIVE SUMMARY
50
PREMIUM INSIGHTS
54
MARKET OVERVIEW
58
  • 5.1 MARKET DYNAMICS
    DRIVERS
    - Increasing number of hospitals and surgeries
    - Increasing adoption of MIS over open surgeries
    - Advantages of robot-assisted surgery & training in rehabilitation therapy
    - Technological advancements
    RESTRAINTS
    - Changing regulatory landscape in medical devices
    - High cost of robotic systems
    OPPORTUNITIES
    - Emerging markets
    - Increasing adoption of advanced robotics in ASCs
    CHALLENGES
    - High degree of market consolidation
  • 5.2 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    DEGREE OF COMPETITION
  • 5.3 TARIFF AND REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.4 KEY REGULATORY GUIDELINES
    US
    EUROPE
    JAPAN
  • 5.5 ECOSYSTEM ANALYSIS
  • 5.6 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Laparoscopy
    - Ablation
    - Electrosurgery
    - Powered surgical products
    COMPLIMENTARY TECHNOLOGIES
    - Robotic surgery
    - Digital solutions (AI, IoT)
    - Medical/Surgical imaging
    ADJACENT TECHNOLOGIES
    - Endoscopes
    - Surgical implants
  • 5.7 VALUE CHAIN ANALYSIS
    RESEARCH & DEVELOPMENT
    PROCUREMENT & PRODUCT DEVELOPMENT
    MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES
  • 5.8 SUPPLY CHAIN ANALYSIS
    PROMINENT COMPANIES
    SMALL & MEDIUM-SIZED COMPANIES
    END USERS
  • 5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    KEY BUYING CRITERIA
  • 5.10 REIMBURSEMENT SCENARIO
  • 5.11 PRICING ANALYSIS
  • 5.12 PATENT ANALYSIS
  • 5.13 TRADE ANALYSIS
  • 5.14 CASE STUDIES
  • 5.15 KEY CONFERENCES AND EVENTS, 2023–2024
  • 5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.17 MINIMALLY INVASIVE SURGERY MARKET: RECESSION IMPACT
  • 5.18 UNMET CUSTOMER NEEDS IN MINIMALLY INVASIVE SURGERY MARKET
  • 5.19 INVESTMENT SCENARIO
MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT
87
  • 6.1 INTRODUCTION
  • 6.2 SURGICAL DEVICES
    HANDHELD INSTRUMENTS
    - Tubular retractors
    - Dilators
    - Suturing instruments
    - Probes
    - Laser fiber devices
    GUIDING DEVICES
    - Guiding catheters
    - Guidewires
    INFLATION SYSTEMS
    - Balloon catheters
    - Balloon inflation systems
    LAPAROSCOPY DEVICES
    - Laparoscopes
    - Trocars & cannulas
    - Graspers & dissectors
  • 6.3 IMAGING & VISUALIZATION SYSTEMS
    ULTRASOUND SYSTEMS
    - Ultrasound to hold largest share of imaging & visualization systems market
    CT SCANNERS
    - Shift toward image-guided interventions and rising disease prevalence to drive market
    MRI SYSTEMS
    - Wide usage and technological advancements to support growth
    X-RAY SYSTEMS
    - Rising emphasis on digital X-ray systems to drive market
    VISUALIZATION SYSTEMS
    - High levels of detail and better outcomes to drive demand
  • 6.4 ELECTROSURGICAL DEVICES
    ELECTROCAUTERY DEVICES
    - Increasing plastic surgeries to drive market
    ELECTROSURGICAL GENERATORS & ACCESSORIES
    - Growing use of disposables and reusable instruments to drive market
  • 6.5 ENDOSCOPY DEVICES
    RIGID ENDOSCOPES
    - Rigid endoscopes to hold largest market share
    FLEXIBLE ENDOSCOPES
    - Rising incidence of cancer to drive demand
    DIAGNOSTIC ENDOSCOPES
    - Role of diagnostic endoscopes to expand due to versatility and sophistication
  • 6.6 MEDICAL ROBOTICS
    ROBOTIC SYSTEMS
    - Accuracy, efficiency, and ability to conduct highly complex procedures to support market growth
    ROBOTIC INSTRUMENTS
    - Rising demand for robotic surgical procedures to drive market
    ROBOTIC SOFTWARE & SERVICES
    - Need for basic training and expertise in robotic systems to drive market
MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION
110
  • 7.1 INTRODUCTION
  • 7.2 CARDIOTHORACIC SURGERY
    GROWING BURDEN OF CARDIOVASCULAR DISEASES TO DRIVE MARKET
  • 7.3 VASCULAR SURGERY
    BENEFITS SUCH AS PRECISE CUTS WITH LIMITED BLOOD LOSS IN VASCULAR SURGERY TO SUPPORT GROWTH
  • 7.4 NEUROLOGICAL SURGERY
    INCREASING NUMBER OF PATIENTS SUFFERING FROM NEUROLOGICAL DISORDERS TO DRIVE SEGMENT GROWTH
  • 7.5 ENT & RESPIRATORY SURGERY
    BENEFITS OF MIS IN HEAD AND NECK DISORDER TREATMENT TO DRIVE MARKET
  • 7.6 COSMETIC SURGERY
    GROWING PREFERENCE FOR COSMETIC PROCEDURES TO DRIVE MARKET
  • 7.7 GASTROINTESTINAL & ABDOMINAL SURGERY
    RISING COLORECTAL CANCER PREVALENCE TO SUPPORT DEMAND
  • 7.8 GYNECOLOGICAL SURGERY
    GROWING NUMBER OF LAPAROSCOPIC HYSTERECTOMIES PERFORMED TO SUPPORT MARKET GROWTH
  • 7.9 UROLOGICAL SURGERY
    INCREASING PREVALENCE OF UROLOGIC CANCERS TO DRIVE ADOPTION OF MIS
  • 7.10 ORTHOPEDIC SURGERY
    RISING GERIATRIC POPULATION AND INCREASE IN ORTHOPEDIC DISORDERS TO DRIVE MARKET
  • 7.11 ONCOLOGICAL SURGERY
    GROWING DEMAND FOR RADIOTHERAPY AND CHEMOTHERAPY TO AFFECT SEGMENT GROWTH
  • 7.12 DENTAL SURGERY
    EMPHASIS ON PREVENTIVE DENTAL CARE TO SUPPORT MARKET GROWTH
  • 7.13 OTHER SURGERIES
MINIMALLY INVASIVE SURGERY MARKET, BY END USER
125
  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS, CLINICS, AND ABLATION CENTERS
    RISING NUMBER OF HOSPITALS AND GOVERNMENT INVESTMENTS TO DRIVE MARKET
  • 8.3 AMBULATORY SURGERY CENTERS
    LOWER COSTS AND SHORTER PATIENT STAYS TO PROPEL GROWTH
  • 8.4 ORTHOPEDIC, EMERGENCY, AND TRAUMA CENTERS
    RISING USE OF ROBOTIC-ASSISTED SURGICAL SYSTEMS IN ORTHOPEDICS, EMERGENCY, AND TRAUMA CARE TO SUPPORT GROWTH
  • 8.5 OTHER END USERS
MINIMALLY INVASIVE SURGERY MARKET, BY REGION
132
  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    NORTH AMERICA: RECESSION IMPACT
    US
    - US to dominate North American market
    CANADA
    - Rising cancer and IBD incidence to drive market
  • 9.3 EUROPE
    EUROPE: RECESSION IMPACT
    GERMANY
    - Well-established healthcare system in Germany to boost usage of instruments
    FRANCE
    - Rising number of hip & knee surgeries to drive market
    UK
    - High incidence of cancer in the UK to boost adoption of MIS instruments
    ITALY
    - Demand for MIS to positively affect market growth
    SPAIN
    - Increasing incidence of CVD to boost adoption of MIS and drive market growth
    REST OF EUROPE
  • 9.4 ASIA PACIFIC
    ASIA PACIFIC: RECESSION IMPACT
    JAPAN
    - Rising geriatric population in Japan to increase prevalence of chronic conditions and support market growth
    CHINA
    - Rising disease prevalence and infrastructural improvements to support market growth
    INDIA
    - Healthcare infrastructure improvements and increasing geriatric population to drive market
    AUSTRALIA
    - Uneven distribution of specialists to hinder market growth
    SOUTH KOREA
    - Growing medical tourism to favor demand for MIS
    REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    LATIN AMERICA: RECESSION IMPACT
    BRAZIL
    - Favorable healthcare policies by government and private organizations to propel market growth
    MEXICO
    - Rising adoption of robotics in cosmetic surgeries to drive market
    REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    MIDDLE EAST & AFRICA: RECESSION IMPACT
    GCC COUNTRIES
    - Growing demand for minimally invasive procedures
COMPETITIVE LANDSCAPE
213
  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 10.3 REVENUE SHARE ANALYSIS
  • 10.4 MARKET SHARE ANALYSIS
    GLOBAL SURGICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2022
    GLOBAL IMAGING & VISUALIZATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2022
    GLOBAL ENDOSCOPY DEVICES MARKET SHARE, BY KEY PLAYER, 2022
    GLOBAL ELECTROSURGICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2022
    GLOBAL MEDICAL ROBOTICS MARKET SHARE, BY KEY PLAYER, 2022
  • 10.5 COMPANY EVALUATION MATRIX (KEY PLAYERS)
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES
    PROGRESSIVE COMPANIES
    STARTING BLOCKS
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    COMPANY BENCHMARKING
  • 10.7 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES & APPROVALS
    DEALS
  • 10.8 COMPANY VALUATION AND FINANCIAL METRICS
  • 10.9 PRODUCT/BRAND COMPARISON
COMPANY PROFILES
233
  • 11.1 KEY PLAYERS
    MEDTRONIC PLC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    JOHNSON & JOHNSON MEDTECH
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    STRYKER CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BOSTON SCIENTIFIC CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    ABBOTT LABORATORIES
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    ZIMMER BIOMET HOLDINGS, INC.
    - Business overview
    - Products offered
    - Recent developments
    B. BRAUN MELSUNGEN AG
    - Business overview
    - Products offered
    NUVASIVE, INC.
    - Business overview
    - Products offered
    - Recent developments
    INTEGRA LIFESCIENCES HOLDINGS CORPORATION
    - Business overview
    - Products offered
    ATEC SPINE
    - Business overview
    - Products offered
    SIEMENS HEALTHINEERS AG
    - Business overview
    - Products offered
    - Recent developments
    COOK MEDICAL
    - Business overview
    - Products offered
    FUJIFILM CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    BECTON, DICKINSON AND COMPANY
    - Business overview
    - Products offered
    - Recent developments
    PHILIPS HEALTHCARE
    - Business overview
    - Products offered
    - Recent developments
    GLOBUS MEDICAL, INC.
    - Business overview
    - Products offered
    - Recent developments
  • 11.2 OTHER PLAYERS
    INTUITIVE SURGICAL INC.
    - Business overview
    - Products offered
    - Recent developments
    KARL STORZ
    - Business overview
    - Products offered
    - Recent developments
    EDWARDS LIFESCIENCES CORPORATION
    - Business overview
    - Products offered
    SMITH+NEPHEW
    - Business overview
    - Products offered
    - Recent developments
    GE HEALTHCARE
    - Business overview
    - Products offered
    - Recent developments
    NIPRO CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    GETINGE AB
    - Business overview
    - Products offered
    CONMED CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    TELEFLEX INCORPORATED
    - Business overview
    - Products offered
    - Recent developments
    ACCURAY
    - Business overview
    - Products offered
    - Recent developments
    OLYMPUS CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    MASIMO
    COOPERSURGICAL INC.
    APPLIED MEDICAL
    RICHARD WOLF
APPENDIX
339
  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 RISK ASSESSMENT ANALYSIS
  • TABLE 2 TECHNOLOGICAL ADVANCEMENTS IN MEDICAL ROBOTS
  • TABLE 3 MINIMALLY INVASIVE SURGERY MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 US FDA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT SEGMENTS (%)
  • TABLE 11 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES
  • TABLE 12 IMPORT DATA FOR MIS MARKET (HS CODE 9021), BY COUNTRY, 2018–2022 (USD THOUSAND)
  • TABLE 13 EXPORT DATA FOR MIS MARKET (HS CODE 3822), BY COUNTRY, 2018–2022 (USD THOUSAND)
  • TABLE 14 CASE STUDY 1: ROLE OF MINIMALLY INVASIVE ROBOT-ASSISTED SURGERY IN UROLOGY
  • TABLE 15 CASE STUDY 2: PIONEERING ROBOT-ASSISTED LATERAL LUMBAR INTERBODY FUSION (LLIF) WITH EXCELSIUSGPS
  • TABLE 16 MINIMALLY INVASIVE SURGERY MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS IN 2023–2024
  • TABLE 17 MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 18 SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 19 SURGICAL DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 20 HANDHELD INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 21 GUIDING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 22 INFLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 23 LAPAROSCOPY DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 24 IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 25 IMAGING & VISUALIZATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 26 ULTRASOUND SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 27 CT SCANNERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 28 MRI SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 29 X-RAY SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 30 VISUALIZATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 31 ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 32 ELECTROSURGICAL DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 33 ELECTROCAUTERY DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 34 ELECTROSURGICAL GENERATORS & ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 35 ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 36 ENDOSCOPY DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 37 RIGID ENDOSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 38 FLEXIBLE ENDOSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 39 DIAGNOSTIC ENDOSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 40 MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 41 MEDICAL ROBOTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 42 ROB0TIC SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 43 ROB0TIC INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 44 ROBOTIC SOFTWARE & SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 45 MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 46 MINIMALLY INVASIVE SURGERY MARKET FOR CARDIOTHORACIC SURGERY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 47 MINIMALLY INVASIVE SURGERY MARKET FOR VASCULAR SURGERY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 48 MINIMALLY INVASIVE SURGERY MARKET FOR NEUROLOGICAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 49 MINIMALLY INVASIVE SURGERY MARKET FOR ENT & RESPIRATORY SURGERY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 50 MINIMALLY INVASIVE SURGERY MARKET FOR COSMETIC SURGERY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 51 MINIMALLY INVASIVE SURGERY MARKET FOR GASTROINTESTINAL & ABDOMINAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 52 MINIMALLY INVASIVE SURGERY MARKET FOR GYNECOLOGICAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 53 MINIMALLY INVASIVE SURGERY MARKET FOR UROLOGICAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 54 MINIMALLY INVASIVE SURGERY MARKET FOR ORTHOPEDIC SURGERY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 55 MINIMALLY INVASIVE SURGERY MARKET FOR ONCOLOGICAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 56 MINIMALLY INVASIVE SURGERY MARKET FOR DENTAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 57 MINIMALLY INVASIVE SURGERY MARKET FOR OTHER SURGERIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 58 MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 59 MINIMALLY INVASIVE SURGERY MARKET FOR HOSPITALS, CLINICS AND ABLATION CENTERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 60 MINIMALLY INVASIVE SURGERY MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 61 MINIMALLY INVASIVE SURGERY MARKET FOR ORTHOPEDIC, EMERGENCY, AND TRAUMA CENTERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 62 MINIMALLY INVASIVE SURGERY MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 63 MINIMALLY INVASIVE SURGERY MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 64 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 65 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 66 NORTH AMERICA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 67 NORTH AMERICA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 68 NORTH AMERICA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 69 NORTH AMERICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 70 NORTH AMERICA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 71 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 72 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 73 US: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 74 US: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 75 US: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 76 US: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 77 US: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 78 US: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 79 CANADA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 80 CANADA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 81 CANADA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 82 CANADA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 83 CANADA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 84 CANADA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 85 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 86 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 87 EUROPE: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 88 EUROPE: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 89 EUROPE: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 90 EUROPE: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 91 EUROPE: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 92 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 93 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 94 GERMANY: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 95 GERMANY: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 96 GERMANY: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 97 GERMANY: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 98 GERMANY: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 99 GERMANY: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 100 FRANCE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 101 FRANCE: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 102 FRANCE: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 103 FRANCE: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 104 FRANCE: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 105 FRANCE: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 106 UK: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 107 UK: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 108 UK: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 109 UK: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 110 UK: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 111 UK: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 112 ITALY: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 113 ITALY: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 114 ITALY: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 115 ITALY: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 116 ITALY: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 117 ITALY: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 118 SPAIN: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 119 SPAIN: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 120 SPAIN: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 121 SPAIN: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 122 SPAIN: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 123 SPAIN: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 124 REST OF EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 125 REST OF EUROPE: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 126 REST OF EUROPE: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 127 REST OF EUROPE: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 128 REST OF EUROPE: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 129 REST OF EUROPE: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 130 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 131 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 132 ASIA PACIFIC: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 133 ASIA PACIFIC: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 134 ASIA PACIFIC: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 135 ASIA PACIFIC: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 136 ASIA PACIFIC: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 137 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 138 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 139 JAPAN: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 140 JAPAN: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 141 JAPAN: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 142 JAPAN: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 143 JAPAN: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 144 JAPAN: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 145 CHINA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 146 CHINA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 147 CHINA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 148 CHINA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 149 CHINA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 150 CHINA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 151 INDIA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 152 INDIA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 153 INDIA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 154 INDIA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 155 INDIA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 156 INDIA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 157 AUSTRALIA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 158 AUSTRALIA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 159 AUSTRALIA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 160 AUSTRALIA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 161 AUSTRALIA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 162 AUSTRALIA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 163 SOUTH KOREA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 164 SOUTH KOREA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 165 SOUTH KOREA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 166 SOUTH KOREA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 167 SOUTH KOREA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 168 SOUTH KOREA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 169 REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 170 REST OF ASIA PACIFIC: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 171 REST OF ASIA PACIFIC: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 172 REST OF ASIA PACIFIC: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 173 REST OF ASIA PACIFIC: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 174 REST OF ASIA PACIFIC: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 175 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 176 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 177 LATIN AMERICA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 178 LATIN AMERICA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 179 LATIN AMERICA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 180 LATIN AMERICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 181 LATIN AMERICA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 182 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 183 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 184 BRAZIL: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 185 BRAZIL: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 186 BRAZIL: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 187 BRAZIL: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 188 BRAZIL: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 189 BRAZIL: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 190 MEXICO: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 191 MEXICO: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 192 MEXICO: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 193 MEXICO: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 194 MEXICO: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 195 MEXICO: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 196 REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 197 REST OF LATIN AMERICA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 198 REST OF LATIN AMERICA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 199 REST OF LATIN AMERICA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 200 REST OF LATIN AMERICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 201 REST OF LATIN AMERICA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 202 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 203 MIDDLE EAST & AFRICA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 204 MIDDLE EAST & AFRICA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 205 MIDDLE EAST & AFRICA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 206 MIDDLE EAST & AFRICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 207 MIDDLE EAST & AFRICA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 208 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 209 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 210 MINIMALLY INVASIVE SURGERY MARKET: DEGREE OF COMPETITION
  • TABLE 211 PRODUCT FOOTPRINT (15 COMPANIES)
  • TABLE 212 REGIONAL FOOTPRINT (15 COMPANIES)
  • TABLE 213 APPLICATION FOOTPRINT (15 COMPANIES)
  • TABLE 214 MINIMALLY INVASIVE SURGERY MARKET: DETAILED LIST OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 215 MINIMALLY INVASIVE SURGERY MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 216 MINIMALLY INVASIVE SURGERY MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2021—OCTOBER 2023)
  • TABLE 217 MINIMALLY INVASIVE SURGERY MARKET: DEALS (JANUARY 2021—OCTOBER 2023)
  • TABLE 218 MEDTRONIC PLC: COMPANY OVERVIEW
  • TABLE 219 MEDTRONIC PLC: PRODUCTS OFFERED
  • TABLE 220 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 221 MEDTRONIC PLC: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 222 JOHNSON & JOHNSON MEDTECH: COMPANY OVERVIEW
  • TABLE 223 JOHNSON & JOHNSON MEDTECH: PRODUCTS OFFERED
  • TABLE 224 JOHNSON & JOHNSON: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 225 JOHNSON & JOHNSON: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 226 STRYKER CORPORATION: COMPANY OVERVIEW
  • TABLE 227 STRYKER CORPORATION: PRODUCTS OFFERED
  • TABLE 228 STRYKER CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 229 STRYKER CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 230 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 231 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 232 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 233 BOSTON SCIENTIFIC CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 234 ABBOTT LABORATORIES: COMPANY OVERVIEW
  • TABLE 235 ABBOTT LABORATORIES: PRODUCTS OFFERED
  • TABLE 236 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 237 ZIMMER BIOMET HOLDINGS, INC.: COMPANY OVERVIEW
  • TABLE 238 ZIMMER BIOMET HOLDINGS: PRODUCTS OFFERED
  • TABLE 239 ZIMMER BIOMET HOLDINGS: PRODUCT APPROVALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 240 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW
  • TABLE 241 B. BRAUN MELSUNGEN: PRODUCTS OFFERED
  • TABLE 242 NUVASIVE, INC: COMPANY OVERVIEW
  • TABLE 243 NUVASIVE INC.: PRODUCTS OFFERED
  • TABLE 244 NUVASIVE, INC: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 245 NUVASIVE INC.: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 246 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY OVERVIEW
  • TABLE 247 INTEGRA LIFESCIENCES HOLDING CORPORATION: PRODUCTS OFFERED
  • TABLE 248 ATEC SPINE: COMPANY OVERVIEW
  • TABLE 249 ATEC SPINE: PRODUCTS OFFERED
  • TABLE 250 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
  • TABLE 251 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED
  • TABLE 252 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 253 SIEMENS HEALTHINEERS AG: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 254 SIEMENS HEALTHINEERS AG: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
  • TABLE 255 COOK MEDICAL: COMPANY OVERVIEW
  • TABLE 256 COOK MEDICAL: PRODUCTS OFFERED
  • TABLE 257 FUJIFILM CORPORATION: COMPANY OVERVIEW
  • TABLE 258 FUJIFILM CORPORATION: PRODUCTS OFFERED
  • TABLE 259 FUJIFILM CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 260 FUJIFILM CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 261 FUJIFILM CORPORATION: EXPANSION (JANUARY 2020–DECEMBER 2023)
  • TABLE 262 FUJIFILM CORPORATION: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023)
  • TABLE 263 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
  • TABLE 264 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
  • TABLE 265 BECTON, DICKINSON AND COMPANY: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 266 BECTON, DICKINSON AND COMPANY: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023)
  • TABLE 267 PHILIPS HEALTHCARE: COMPANY OVERVIEW
  • TABLE 268 PHILIPS HEALTHCARE: PRODUCTS OFFERED
  • TABLE 269 PHILIPS HEALTHCARE: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 270 PHILIPS HEALTHCARE: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 271 GLOBUS MEDICAL, INC.: COMPANY OVERVIEW
  • TABLE 272 GLOBUS MEDICAL: PRODUCTS OFFERED
  • TABLE 273 GLOBUS MEDICAL: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 274 INTUITIVE SURGICAL INC.: COMPANY OVERVIEW
  • TABLE 275 INTUITIVE SURGICAL INC.: PRODUCTS OFFERED
  • TABLE 276 INTUITIVE SURGICAL, INC.: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 277 INTUITIVE SURGICAL, INC.: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 278 KARL STORZ: COMPANY OVERVIEW (2022)
  • TABLE 279 KARL STORZ: PRODUCTS OFFERED
  • TABLE 280 KARL STORZ: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 281 KARL STORZ: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
  • TABLE 282 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW
  • TABLE 283 EDWARDS LIFESCIENCES CORPORATION: PRODUCTS OFFERED
  • TABLE 284 SMITH+NEPHEW: COMPANY OVERVIEW
  • TABLE 285 SMITH+NEPHEW: PRODUCTS OFFERED
  • TABLE 286 SMITH+NEPHEW: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
  • TABLE 287 SMITH+ NEPHEW: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 288 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 289 GE HEALTHCARE: PRODUCTS OFFERED
  • TABLE 290 GE HEALTHCARE: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
  • TABLE 291 GE HEALTHCARE: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 292 NIPRO CORPORATION: COMPANY OVERVIEW
  • TABLE 293 NIPRO CORPORATION: PRODUCTS OFFERED
  • TABLE 294 NIPRO CORPORATION: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
  • TABLE 295 GETINGE AB: COMPANY OVERVIEW
  • TABLE 296 GETINGE AB: PRODUCTS OFFERED
  • TABLE 297 CONMED CORPORATION: COMPANY OVERVIEW
  • TABLE 298 CONMED CORPORATION: PRODUCTS OFFERED
  • TABLE 299 CONMED CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 300 TELEFLEX INCORPORATED: COMPANY OVERVIEW
  • TABLE 301 TELEFLEX INCORPORATED: PRODUCTS OFFERED
  • TABLE 302 TELEFLEX INCORPORATION: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
  • TABLE 303 ACCURAY: COMPANY OVERVIEW
  • TABLE 304 ACCURAY: PRODUCTS OFFERED
  • TABLE 305 ACCURAY: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
  • TABLE 306 ACCURAY: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 307 OLYMPUS CORPORATION: COMPANY OVERVIEW
  • TABLE 308 OLYMPUS CORPORATION: PRODUCTS OFFERED
  • TABLE 309 OLYMPUS CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 310 OLYMPUS CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
LIST OF FIGURES
 
  • FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 4 MINIMALLY INVASIVE SURGERY MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
  • FIGURE 5 MINIMALLY INVASIVE SURGERY MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 6 TOP-DOWN APPROACH
  • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • FIGURE 8 MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 9 MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 10 MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 GEOGRAPHIC SNAPSHOT OF MINIMALLY INVASIVE SURGERY MARKET
  • FIGURE 12 INCREASING ADOPTION OF MIS OVER OPEN SURGERIES TO DRIVE MARKET DURING FORECAST PERIOD
  • FIGURE 13 NORTH AMERICA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 14 HOSPITALS, CLINICS, AND ABLATION CENTERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • FIGURE 15 FRANCE TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 16 MINIMALLY INVASIVE SURGERY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 17 MINIMALLY INVASIVE SURGERY MARKET: ECOSYSTEM
  • FIGURE 18 MINIMALLY INVASIVE SURGERY MARKET: KEY PLAYERS
  • FIGURE 19 MINIMALLY INVASIVE SURGERY MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 20 MINIMALLY INVASIVE SURGERY MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 21 AVERAGE SELLING PRICE OF MINIMALLY INVASIVE PRODUCTS, BY PRODUCT (FY 2021-2023)
  • FIGURE 22 AVERAGE SELLING PRICE TREND, BY REGION
  • FIGURE 23 PATENT DETAILS FOR MINIMALLY INVASIVE SURGERY DEVICES (JANUARY 2013–DECEMBER 2023)
  • FIGURE 24 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX
  • FIGURE 25 NUMBER OF INVESTOR DEALS IN MINIMALLY INVASIVE SURGERY MARKET, BY KEY PLAYER, 2018–2022
  • FIGURE 26 VALUE OF INVESTOR DEALS IN MINIMALLY INVASIVE SURGERY MARKET, BY KEY PLAYER, 2018–2022 (USD MILLION)
  • FIGURE 27 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET SNAPSHOT
  • FIGURE 28 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET SNAPSHOT
  • FIGURE 29 OVERVIEW OF STRATEGIES ADOPTED BY MINIMALLY INVASIVE SURGERY PLAYERS
  • FIGURE 30 REVENUE SHARE ANALYSIS FOR KEY PLAYERS, 2018–2022 (USD MILLION)
  • FIGURE 31 SURGICAL DEVICES MARKET SHARE ANALYSIS, 2022
  • FIGURE 32 IMAGING & VISUALIZATION SYSTEMS MARKET SHARE ANALYSIS, 2022
  • FIGURE 33 ENDOSCOPY DEVICES MARKET SHARE ANALYSIS, 2022
  • FIGURE 34 ELECTROSURGICAL DEVICES MARKET SHARE ANALYSIS, 2022
  • FIGURE 35 MEDICAL ROBOTICS MARKET SHARE ANALYSIS, 2022
  • FIGURE 36 MINIMALLY INVASIVE SURGERY MARKET SHARE, BY PLAYER (2023)
  • FIGURE 37 MINIMALLY INVASIVE SURGERY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022
  • FIGURE 38 COMPANY FOOTPRINT (15 COMPANIES)
  • FIGURE 39 MINIMALLY INVASIVE SURGERY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2022
  • FIGURE 40 EV/EBITDA OF KEY VENDORS
  • FIGURE 41 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 42 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL (2023)
  • FIGURE 43 MEDTRONIC PLC: COMPANY SNAPSHOT (2023)
  • FIGURE 44 JOHNSON & JOHNSON MEDTECH: COMPANY SNAPSHOT (2022)
  • FIGURE 45 STRYKER CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 46 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 47 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
  • FIGURE 48 ZIMMER BIOMET HOLDINGS: COMPANY SNAPSHOT (2022)
  • FIGURE 49 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022)
  • FIGURE 50 NUVASIVE, INC: COMPANY SNAPSHOT (2022)
  • FIGURE 51 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 52 ATEC SPINE: COMPANY SNAPSHOT (2022)
  • FIGURE 53 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022)
  • FIGURE 54 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 55 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
  • FIGURE 56 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2022)
  • FIGURE 57 GLOBUS MEDICAL, INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 58 INTUITIVE SURGICAL INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 59 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 60 SMITH+NEPHEW: COMPANY SNAPSHOT (2022)
  • FIGURE 61 GENERAL ELECTRIC: COMPANY SNAPSHOT (2022)
  • FIGURE 62 NIPRO CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 63 GETINGE AB: COMPANY SNAPSHOT (2022)
  • FIGURE 64 CONMED CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 65 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022)
  • FIGURE 66 ACCURAY: COMPANY SNAPSHOT (2022)
  • FIGURE 67 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the minimally invasive surgery market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in product therapy markets. The primary sources from the demand side include medical OEMs, Analytical instrument OEMs, CDMOs, and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

Minimally Invasive Surgery Market Size, and Share

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2021, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = <USD 50 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Estimation Methodology

In this report, the minimally invasive surgery market size was determined using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the minimally invasive surgery market business were determined through various insights gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and key marketing executives.

To calculate the global market value, segmental revenues were calculated based on the revenue mapping of major solution/service providers. This process involved the following steps:

  • Generating a list of major global players operating in the minimally invasive surgery market.
  • Mapping annual revenues generated by major global players from the minimally invasive surgery market(or nearest reported business unit/product category)
  • Revenue mapping of key  players to cover a major share of the global market, as of 2022
  • Extrapolating the global value of the minimally invasive surgery market

Global Minimally Invasive Surgery Market: Bottom-Up Approach

Minimally Invasive Surgery Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Minimally Invasive Surgery: Top-Down Approach

Minimally Invasive Surgery Market Size, and Share

Minimally Invasive Surgery Market Size, and Share

Data Triangulation

After arriving at the overall market size from the market size estimation process explained above, the minimally invasive surgery market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the minimally invasive surgery market was  validated using both top-down and bottom-up approaches.

Market Definition

Minimally invasive surgery (MIS) is a surgical procedure done in a manner that causes little to no trauma or injury to a patient. MIS is executed through a cannula using lasers, endoscopes or laparoscopes. MIS involves less bleeding, smaller amounts of anesthesia, less pain, and minimal scarring than other procedures. The surgical instruments used to make minute incisions in the body and perform MIS procedures are minimally invasive.

Key Stakeholders

  • Manufacturers and distributors of minimally invasive surgical instruments
  • Hospitals and clinics
  • Ambulatory surgical centers
  • Research and development (R&D) companies
  • Clinical research organizations
  • Research laboratories and academic institutes
  • Minimally invasive surgical instruments service providers
  • Government associations
  • Venture capitalists and investors

Objectives of the Study

  • To define, describe, and forecast the minimally invasive surgery market on Product, application and end user.
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze the micro markets concerning individual growth trends, prospects,  and contributions to the total market.
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
  • To profile the key market players and comprehensively analyze their market shares and core competencies.
  • To forecast the revenue of the market segments concerning five main regions, namely, North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), the Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa.
  • To track and analyze competitive developments such as new product launches and approvals; agreements, partnerships, expansions, acquisitions; and collaborations in the minimally invasive surgery market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global minimally invasive surgery market

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top thirteen companies.

Company Information

  • Detailed analysis and profiling of additional market players (up to 15)

Geographic Analysis

  • Further breakdown of the Rest of Europe's minimally invasive surgery market Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal among other
  • Further breakdown of the Rest of Asia Pacific minimally invasive surgery market Singapore, Taiwan, New Zealand, Philippines, Malaysia, and other APAC countries
  • Further breakdown of the Rest of the world minimally invasive surgery market Latin America, MEA, and Africa

Previous Versions of this Report

Minimally Invasive Medical Robotics, Imaging & Visualization Systems & Surgical Instruments Market Forecasts to 2016 (DA VINCI, Robodoc, Spine Assist, Neuromate, Ultrasound, CT, MRI, X-RAY Imaging, Electrosurgical Devices,  Handheld Instruments, Guiding Devices, Inflation Systems & Auxiliary Devices) Global Trends & Competitive Analysis

Report Code MD 1250
Published in Jul, 2012, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Minimally Invasive Surgery Market

DMCA.com Protection Status